Dr. Pascal O. Zinn is an Assistant Professor and the Director of the Adult Neurosurgical Oncology Program, Director of Molecular Tumor Biology and Personalized Precision Therapy Lab, and Director of Neurosurgical Oncology Tissue Bank at the University of Pittsburgh. He obtained his MD from the University of Zurich, Switzerland in 2007 and his Ph.D. from the University of Lausanne, Switzerland in 2012. He has undergone subspecialty training in tumor biology and neurosurgical oncology at the Dana-Farber Harvard Cancer Institute and the MD Anderson Cancer Center in state-of-the-art, patient-tailored treatment paradigms. Dr. Zinn’s research program focus is on patient-centered care for brain and spinal tumors. Utilizing humanoid brain organoid tumor models, he simulates the patient’s condition in the laboratory and thus studies the origins of how tumors form and how tumors can be treated using tumor genetics precision approaches. Furthermore, he is developing personalized biologically adaptable and patient-tailored, virus-based therapies for brain cancer. Dr. Zinn has received numerous awards, such as the Castle Connolly Top Doctors in America in 2024, the Natus Award from the Congress of Neurological Surgeons in 2022, the Faculty Teaching Award from the University of Pittsburgh Department of Neurosurgery in 2022 and the Kinjiro Iwata Award from Baylor College of Medicine in 2019.